Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Prestige Consumer Healthcare Inc. (PBH : NYSE)
 
 • Company Description   
Prestige Consumer Healthcare Inc. and its subsidiaries develop, manufacture, market, sell and distributes over-the-counter (OTC) healthcare and household cleaning products in the U.S., Canada, Australia and other international markets. It provides its products to mass merchandisers as well as drug, food, dollar, convenience, club stores and e-commerce channel. It has two segments: North American OTC Healthcare and International OTC Healthcare. Some of the major brands include products like BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat treatments and mouth pain products, Clear Eyes eye care products, Compound Wwart removers, Dramamine Non-Drowsy naturals, Efferdent denture cleansers, Luden's throat drops, Hydralyte for oral rehydration, Fess nasal saline spray, Gaviscon for upset stomach remedies, etc. Its well-known acquisitions include Akorn Operating Company's consumer brands, Fleet, DenTek Holdings, Inc, Hydralyte and BC & Goody's.

Number of Employees: 535

 
 • Price / Volume Information   
Yesterday's Closing Price: $56.27 Daily Weekly Monthly
20 Day Moving Average: 307,996 shares
Shares Outstanding: 50.20 (millions)
Market Capitalization: $2,824.71 (millions)
Beta: 0.58
52 Week High: $63.83
52 Week Low: $49.09
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 6.25% 14.87%
12 Week -5.48% 4.04%
Year To Date -7.22% 11.28%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
660 WHITE PLAINS ROAD SUITE 250
-
TARRYTOWN,NY 10591
USA
ph: 914-524-6800
fax: 302-674-5266
irinquiries@prestigebrands.com http://www.prestigebrands.com
 
 • General Corporate Information   
Officers
Ronald M. Lombardi - President and Chief Executive Officer
Christine Sacco - Chief Financial Officer
John E. Byom - Director
Celeste A. Clark - Director
Christopher J. Coughlin - Director

Peer Information
Prestige Consumer Healthcare Inc. (LENXQ)
Prestige Consumer Healthcare Inc. (CENT)
Prestige Consumer Healthcare Inc. (FTDL)
Prestige Consumer Healthcare Inc. (BTH)
Prestige Consumer Healthcare Inc. (JAH)
Prestige Consumer Healthcare Inc. (NHTC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: CONSM PD-MISC DIS
Sector: Consumer Discretionary
CUSIP: 74112D101
SIC: 2834
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 50.20
Most Recent Split Date: (:1)
Beta: 0.58
Market Capitalization: $2,824.71 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.04 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $4.20 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 8.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 13.38
Trailing 12 Months: 13.86
PEG Ratio: 1.67
Price Ratios
Price/Book: 1.79
Price/Cash Flow: 11.64
Price / Sales: 2.60
EPS Growth
vs. Year Ago Period: 15.19%
vs. Previous Quarter: -8.08%
Sales Growth
vs. Year Ago Period: 12.27%
vs. Previous Quarter: -2.74%
ROE
03/31/22 - 13.82
12/31/21 - 13.90
09/30/21 - 13.71
ROA
03/31/22 - 5.67
12/31/21 - 5.58
09/30/21 - 5.39
Current Ratio
03/31/22 - 2.04
12/31/21 - 2.04
09/30/21 - 2.05
Quick Ratio
03/31/22 - 1.21
12/31/21 - 1.25
09/30/21 - 1.32
Operating Margin
03/31/22 - 18.99
12/31/21 - 18.90
09/30/21 - 18.65
Net Margin
03/31/22 - 18.90
12/31/21 - 17.85
09/30/21 - 17.56
Pre-Tax Margin
03/31/22 - 24.15
12/31/21 - 22.87
09/30/21 - 22.51
Book Value
03/31/22 - 31.43
12/31/21 - 30.25
09/30/21 - 29.17
Inventory Turnover
03/31/22 - 4.24
12/31/21 - 4.13
09/30/21 - 3.86
Debt-to-Equity
03/31/22 - 0.94
12/31/21 - 1.01
09/30/21 - 1.09
Debt-to-Capital
03/31/22 - 48.42
12/31/21 - 50.28
09/30/21 - 52.24
 

Powered by Zacks Investment Research ©